Rang	Name	Position
1	Mr. Jason M. Hollar	CEO & Director
2	Mr. Aaron E. Alt J.D.	Chief Financial Officer
3	Ms. Jessica L. Mayer	Chief Legal & Compliance Officer
4	Mr. Stephen M. Mason	Chief Executive Officer of GMPD segment
5	Ms. Deborah L. Weitzman	Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment
6	Ms. Mary C. Scherer	Senior VP & Chief Accounting Officer
7	Mr. David Frost	Vice President of Investor Relations
8	Ms. Valerie Christine Pitteroff	Chief Human Resources Officer
9	Mr. Craig Cowman	President of Biopharma Solutions & Strategic Sourcing
10	Mr. Ben Brinker	President of Global Operations & Supply Chain

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	11,44%	6,48 Mrd. USD
2	Vanguard Capital Management, LLC	6,60%	3,74 Mrd. USD
3	Wellington Management Company LLP	6,42%	3,64 Mrd. USD
4	Vanguard Portfolio Management, LLC	5,92%	3,36 Mrd. USD
5	State Street Corp	5,17%	2,93 Mrd. USD
6	Geode Capital Management, LLC	2,80%	1,58 Mrd. USD
7	Amvescap Plc.	2,05%	1,16 Mrd. USD
8	Morgan Stanley - Brokerage Accounts	2,00%	1,13 Mrd. USD
9	WCM Investment Management	1,78%	1,01 Mrd. USD
10	NORGES BANK	1,61%	0,91 Mrd. USD
11	Bank of America Corp	1,25%	0,71 Mrd. USD
12	Northern Trust Corp	1,24%	0,70 Mrd. USD
13	JPMorgan Chase & Co	1,15%	0,65 Mrd. USD
14	The Goldman Sachs Group Inc	1,03%	0,58 Mrd. USD
15	T. Rowe Price Associates, Inc.	0,97%	0,55 Mrd. USD
16	UBS Asset Mgmt Americas Inc	0,96%	0,54 Mrd. USD
17	BNP Paribas Arbitrage, SA	0,91%	0,52 Mrd. USD
18	FMR Inc	0,89%	0,51 Mrd. USD
19	Victory Capital Management Inc.	0,85%	0,48 Mrd. USD
20	Legal & General Group PLC	0,80%	0,45 Mrd. USD